EMvision Medical Devices Ltd. (AU:EMV)
ASX:EMV
Total Valuation
EMvision Medical Devices Ltd. has a market cap or net worth of AU$145.91M. The enterprise value is AU$127.28M.
Market CapAU$145.91M
Enterprise ValueAU$127.28M
Share Statistics
EMvision Medical Devices Ltd. has 92,938,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,938,610
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
EMvision Medical Devices Ltd.’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -62.80%.
Return on Equity (ROE)-1.06
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-62.80%
Return on Capital Employed (ROCE)-0.64
Revenue Per Employee109.82K
Profits Per Employee0.00
Employee Count46
Asset Turnover0.32
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of EMvision Medical Devices Ltd. is ―. EMvision Medical Devices Ltd.’s PEG ratio is -0.07.
PE Ratio―
PS Ratio29.42
PB Ratio16.01
Price to Fair Value16.01
Price to FCF-18.85
Price to Operating Cash Flow-15.65
PEG Ratio-0.07
Income Statement
In the last 12 months, EMvision Medical Devices Ltd. had revenue of 5.05M and earned -9.81M in profits. Earnings per share was -0.11.
Revenue5.05M
Gross Profit5.05M
Operating Income-8.13M
Pretax Income-8.36M
Net Income-9.81M
EBITDA-8.71M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -8.94M and capital expenditures -78.32K, giving a free cash flow of -9.02M billion.
Operating Cash Flow-8.94M
Free Cash Flow-9.02M
Free Cash Flow per Share-0.10
Dividends & Yields
EMvision Medical Devices Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change-12.83%
50-Day Moving Average1.70
200-Day Moving Average1.81
Relative Strength Index (RSI)42.56
Average Volume (3m)120.98K
Important Dates
EMvision Medical Devices Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateFeb 22, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
EMvision Medical Devices Ltd. as a current ratio of 4.90, with Debt / Equity ratio of 20.37%
Current Ratio4.90
Quick Ratio4.90
Debt to Market Cap0.02
Net Debt to EBITDA0.79
Interest Coverage Ratio-91.78
Taxes
In the past 12 months, EMvision Medical Devices Ltd. has paid 1.45M in taxes.
Income Tax1.45M
Effective Tax Rate-0.17
Enterprise Valuation
EMvision Medical Devices Ltd. EV to EBITDA ratio is -16.27, with an EV/FCF ratio of -17.97.
EV to Sales28.05
EV to EBITDA-16.27
EV to Free Cash Flow-17.97
EV to Operating Cash Flow-18.08
Balance Sheet
EMvision Medical Devices Ltd. has AU$17.56M in cash and marketable securities with AU$4.02M in debt, giving a net cash position of AU$13.54M billion.
Cash & Marketable SecuritiesAU$17.56M
Total DebtAU$4.02M
Net CashAU$13.54M
Net Cash Per ShareAU$0.15
Tangible Book Value Per ShareAU$0.10
Margins
Gross margin is 86.26%, with operating margin of -160.91%, and net profit margin of -194.10%.
Gross Margin86.26%
Operating Margin-160.91%
Pretax Margin-165.40%
Net Profit Margin-194.10%
EBITDA Margin-172.44%
EBIT Margin-175.06%
Analyst Forecast
The average price target for EMvision Medical Devices Ltd. is AU$3.15, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$3.15
Price Target Upside77.97% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-257.32%